return to news
  1. Stocks to watch, June 3: NHPC, IT stocks, Alkem Labs, IndiGo, Canara Bank, Mankind Pharma

Market News

Stocks to watch, June 3: NHPC, IT stocks, Alkem Labs, IndiGo, Canara Bank, Mankind Pharma

Swati Verma

6 min read | Updated on June 03, 2026, 07:59 IST

SUMMARY

Stocks to watch: NHPC shares will be in focus as the government on Tuesday decided to exercise the green shoe option in the 6% stake sale in the state-owned NHPC through an offer for sale (OFS), following an overwhelming response from investors on the first day of subscription.

Shares in focus, June 3, 2026

The GIFT NIFTY futures suggest that the NIFTY50 index will open 121 points lower. Image: Shutterstock

Stocks to watch: The domestic stock market is expected to open in the red on Wednesday, June 3. The GIFT NIFTY futures suggest that the NIFTY50 index will open 121 points lower.
Open FREE Demat Account within minutes!
Join now
Here is a list of stocks that may remain in focus today.
NHPC: Shares will be in focus as the government on Tuesday decided to exercise the green shoe option in the 6% stake sale in the state-owned NHPC through an Offer for Sale (OFS), following an overwhelming response from investors on the first day of subscription.

The OFS received an encouraging response from investors and was oversubscribed 3.47 times on the first day.

"Offer for sale at NHPC Limited received an enthusiastic response from investors and was oversubscribed 3.47 times on the first day. Allocation will be on a price priority basis. The government has decided to exercise the entire green shoe option. Retail investors and employees get to bid on 3rd June 2026," Department of Investment and Public Asset Management (DIPAM) Secretary Arunish Chawla said in a post on X.

IT stocks: Shares of IT companies will remain in focus as the tech stocks continue to rally on Wall Street.

The S&P 500 ticked up to a record close after reaching a new all-time high on Tuesday as traders monitored the latest U.S.-Iran developments as well as moves in major tech names. The broad-based index advanced 0.13% to end at 7,609.78 for its first close above the 7,600 threshold, while the Dow Jones Industrial Average gained 228.91 points, or 0.45%, to 51,307.79.

The latter also rose to a new all-time intraday high earlier in the session. The Nasdaq Composite eked out a gain of 0.03% to end at 27,093.90.

Mankind Pharma: Mankind Pharma, which held a 90% stake in Upakarma Ayurveda, has acquired the remaining 10% stake in Upakarma from Kaushcorp Media LLP through a share purchase agreement (“SPA”) dated June 2, 2026.

As a result of this acquisition, Upakarma has become a WOS of MLS and a step-down WOS of the company.

REC Ltd: REC Power Development and Consultancy Limited (RECPDCL), a wholly owned subsidiary of REC, has transferred two project-specific SPVs (Special Purpose Vehicles) to private entities.

Hampapura Power Transmission and Mekhali Power Transmission were transferred to the successful bidders, Resonia Ltd and Dilip Buildcon, on May 30, 2026, REC said in a statement.

A public sector undertaking (PSU) of the Ministry of Power, REC provides long-term loans and other financing solutions to both public and private sector companies for building infrastructure assets in the country.

Titan Company: Leading watchmaker Titan is making a significant investment in the premiumisation of the segment, anticipating that watches priced above ₹25,000 will account for nearly one-fourth of its revenue within the next 2-3 years, according to a company official's statement on Tuesday.

Titan is also expanding the store count of Helios and Helios Luxe, its retail chain that sells watches priced at ₹25,000 and above, as the premium and accessible luxury segments are growing at a 30% CAGR, Titan Watch Division CEO Kuruvilla Markose told PTI.

"We have close to 10 stores of Helios Luxe, and we are adding more as we go along. In this current financial year, we hope to expand that number closer to 30, and for Helios, we have close to 300 stores, and they are doing extremely well. This format for us is growing rapidly," said Markose.

Alkem Laboratories: Two promoter entities of Alkem Laboratories on Tuesday divested a 1.5% stake in the pharmaceutical company for ₹930 crore through open market transactions.

A total of 17,88,220 shares representing a 1.49% stake were offloaded in Mumbai-based Alkem Laboratories by Jayanti Sinha and the Samprada & Nanhamati Singh Family Trust, as per the block deal data available on the NSE.

The shares were disposed of at an average price of ₹5,200 apiece, taking the transaction value to ₹929.87 crore.

Following the stake sale, Jayanti Sinha, part of the promoter group of Alkem Laboratories, has exited the firm. Also, the holding of promoters dropped to 49.71 per cent from 51.20%.

Meanwhile, ICICI Prudential Mutual Fund (MF), HDFC MF, Edelweiss MF, Nippon India MF, DSP MF, BNP Paribas, Societe Generale, Morgan Stanley, and Goldman Sachs were the buyers who picked up the shares.

Shares of Alkem Laboratories fell 1.42% to close at ₹5,239 apiece on the NSE.

InterGlobe Aviation (IndiGo): The airline on Tuesday announced discontinuing its flights to Manchester from August 31, less than a year after launching the services, amid escalating operational costs and airspace constraints.

The country's largest airline, which has significantly expanded its international operations, would also be returning one Boeing 787-9 Dreamliner aircraft leased from Norse Atlantic Airways following the decision to stop Manchester flights.

Currently, three weekly and four weekly services are operated to Manchester (UK) from Delhi and Mumbai, respectively. The flights started in July 2025.

Once these flights are discontinued from August 31, there will be no direct air connectivity between Indian cities and Manchester.

In a statement, IndiGo said it would temporarily discontinue flights to and from Manchester from August 31 due to continuing international airspace constraints leading to significantly increased flight duration and a challenging cost environment.

Canara Bank: Shares of Canara Bank will be in the spotlight on Wednesday, June 3, as its board of directors approved a plan to raise up to ₹8,500 crore in capital via debt instruments for the 2026-27 financial year (FY27).

“The stock exchanges are hereby informed that the Board of Directors of the bank, in its meeting held today on 02.06.2026, has approved the capital raising plan of the bank for the financial year 2026-27 amounting to ₹8,500 crore by way of debt instruments (Additional Tier I/Tier II bonds)," the regulator filing read.

Under the plan, Canara Bank will raise capital up to ₹4,500 crore through Basel III-compliant Additional Tier I Bonds and ₹4,000 crore via Tier II Bonds for FY27, subject to market conditions and necessary approvals.

Adani Ports: The company clocked a cargo volume of 48.3 MMT in May '26, registering a 16% YoY growth. Logistics rail volume during May '26 stood at 48,170 TEUs (-19% YoY). YTD May '26, logistics rail volumes stood at 96,660 TEUs (-18% YoY).
With inputs from PTI
Disclaimer: This article is purely for informational purposes and should not be considered investment advice from Upstox. Please consult with a financial advisor before making any investment decisions.

About The Author

Swati Verma
Swati Verma is a business journalist with over 11 years of experience. She writes on equities, corporate earnings, sectoral trends, and industry outlook, among others. At Upstox, she leads financial markets coverage.

Next Story